- Home
- CRMD vs ABL Comparison
CRMD vs ABL Comparison
Compare CRMD & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- ABL
- Stock Information
- Founded
- CRMD 2006
- ABL 2004
- Country
- CRMD United States
- ABL United States
- Employees
- CRMD N/A
- ABL N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- ABL Investment Managers
- Sector
- CRMD Health Care
- ABL Finance
- Exchange
- CRMD Nasdaq
- ABL Nasdaq
- Market Cap
- CRMD 464.7M
- ABL 687.7M
- IPO Year
- CRMD 2010
- ABL N/A
- Fundamental
- Price
- CRMD $12.03
- ABL $8.38
- Analyst Decision
- CRMD Strong Buy
- ABL Strong Buy
- Analyst Count
- CRMD 6
- ABL 4
- Target Price
- CRMD $15.00
- ABL $13.50
- AVG Volume (30 Days)
- CRMD 2.1M
- ABL 438.6K
- Earning Date
- CRMD 05-06-2025
- ABL 05-08-2025
- Dividend Yield
- CRMD N/A
- ABL N/A
- EPS Growth
- CRMD N/A
- ABL N/A
- EPS
- CRMD 0.28
- ABL N/A
- Revenue
- CRMD $82,553,827.00
- ABL $111,923,786.00
- Revenue This Year
- CRMD $207.65
- ABL $64.80
- Revenue Next Year
- CRMD $50.13
- ABL $24.39
- P/E Ratio
- CRMD $43.34
- ABL N/A
- Revenue Growth
- CRMD N/A
- ABL 68.56
- 52 Week Low
- CRMD $3.61
- ABL $6.34
- 52 Week High
- CRMD $13.85
- ABL $12.40
- Technical
- Relative Strength Index (RSI)
- CRMD 76.78
- ABL 62.22
- Support Level
- CRMD $8.72
- ABL $8.11
- Resistance Level
- CRMD $9.82
- ABL $8.47
- Average True Range (ATR)
- CRMD 0.65
- ABL 0.25
- MACD
- CRMD 0.42
- ABL -0.00
- Stochastic Oscillator
- CRMD 94.49
- ABL 80.85
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About ABL Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.